Personalized P2Y12 Inhibitor Treatment Are We Ready to Go?

被引：2
|
作者：
ten Berg, Jurrien M. [1 ]
Janssen, Paul W. A. [1 ]
机构：
[1] St Antonius Hosp, Dept Cardiol, POB 2500, NL-3432 Nieuwegein, Netherlands
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2020年 / 13卷 / 05期
关键词：
CYP2C19; genotyping; P2Y(12) inhibitors; tailored treatment; CLOPIDOGREL;
D O I：
10.1016/j.jcin.2020.01.221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：631 / 633
页数：3
相关论文
共 50 条
  • [1] P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
    Kim, Juwon
    Jang, Woo Jin
    Lee, Wang Soo
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Bin Song, Young
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Oh, Ju-Hyeon
    Chun, Woo Jung
    Park, Yong Hwan
    Im, Eul-Soon
    Jeong, Jin-Ok
    Cho, Byung Ryul
    Oh, Seok Kyu
    Yun, Kyeong Ho
    Cho, Deok-Kyu
    Lee, Jong-Young
    Koh, Young-Youp
    Bae, Jang-Whan
    Choi, Jae Woong
    Yoon, Hyuck Jun
    Lee, Seung Uk
    Cho, Jang Hyun
    Choi, Woong Gil
    Rha, Seung-Woon
    Hahn, Joo-Yong
    HEART, 2021, 107 (13) : 1077 - 1083
  • [2] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
  • [3] P2Y12 Inhibitor-Based Monotherapy
    Choudhary, Rahul
    Deora, Surender
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1273 - 1274
  • [4] Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor
    Beavers, Craig J.
    Effoe, Samuel. Aaron
    Dobesh, Paul P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 161 - 167
  • [5] Potent P2Y12 Inhibitor Therapy for All?
    Brown, Oliver I.
    Rossington, Jennifer A.
    Hoye, Angela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (11) : 1425 - 1425
  • [6] Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
    Dobesh, Paul P.
    PHARMACOTHERAPY, 2009, 29 (09): : 1089 - 1102
  • [7] REPLY: P2Y12 Inhibitor-Based Monotherapy
    Angiolillo, Dominick J.
    Baber, Usman
    Dangas, George D.
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1274 - 1275
  • [8] Attenuation of the P2Y12 Inhibitor Effect with Morphine is likely
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2020, 9 (02)
  • [9] Ticagrelor: the first novel reversible P2Y12 inhibitor
    Htun, Wah Wah
    Steinhubl, Steven R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (02) : 237 - 245
  • [10] Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?
    Chandiramani, Rishi
    Mehta, Adhya
    Blumenthal, Roger S.
    Williams, Marlene S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (11) : 649 - 658
12345